| Message | Subject | Recs | Date/Time (ET) |
| Royalty Pharma Announces Proposal To Acquire Elan
http://www.siliconinvestor. | Elan Corporation, plc (ELN) | | 02/25/2013 06:14:06 AM |
|
Royalty Pharma Announces Proposal To Acquire ElanAnnouncement Made Under Rul | Munch-a-Biotech Today | | 02/25/2013 06:03:27 AM |
| Biotech vets back $22M A round for neuroscience startup
April 5, 2012 | B | Biotechnology Value Fund, L.P. | | 04/08/2012 09:27:42 AM |
| Biotech Stocks To Watch In 2012 [SeekingAlpha]
February 6, 2012
[b][i]Ar | Array Pharmaceuticals ARRY | | 02/06/2012 05:19:18 PM |
| Myriad Genetics Acquires Exclusive Rights to RAD51C Gene RAD51C Increases a Pat | Myriad Genetics, Inc. (MYGN) | | 01/19/2012 12:22:01 AM |
| Array's CEO Bob Conway resigns after 12 years with company
Headquartered i | Array Pharmaceuticals ARRY | | 01/18/2012 01:07:57 AM |
| Small-Cap, Biotech-Focused Hedge Fund BVF's Top Q3 Picks
December 28, 2011 | | Biotechnology Value Fund, L.P. | | 12/29/2011 02:04:01 PM |
| Controversy Over Cholesterol Testing for Children
[url=http://blogs.forbes. | Indications -- cardiovascular | | 11/12/2011 10:59:11 AM |
| Data about Early Use and Long-Term Benefit of TYSABRI Presented at 5th Joint Tri | Elan Corporation, plc (ELN) | 1 | 10/19/2011 09:28:21 AM |
| Google, Tech Investor Back Company That Aims To Bring DNA Sequencing To Cancer P | Biotechnology Value Fund, L.P. | | 10/18/2011 09:26:27 AM |
| Sangamo BioSciences Announces Phase 2b Trial of SB-509 in Diabetic Neuropathy Di | Sangamo BioSciences, Inc. SGMO | | 10/03/2011 08:09:01 AM |
| Sangamo BioSciences to Host Conference Call to Discuss Results From Phase 2b Tri | biotech binary events | | 09/30/2011 10:07:13 PM |
| Sangamo BioSciences to Host Conference Call to Discuss Results From Phase 2b Tri | Sangamo BioSciences, Inc. SGMO | | 09/30/2011 10:02:35 PM |
| Topline Results: A Randomized Phase 2 Study of Selumetinib in Patients with KRAS | Array Pharmaceuticals ARRY | | 09/30/2011 09:27:56 AM |
| Myriad Genetics secures option to buy Crescendo Biosciences
On Thursday Sept | Myriad Genetics, Inc. (MYGN) | | 09/09/2011 01:25:46 AM |
| Myriad Genetics: This Leading Developer of Diagnostic Products Is Catching The E | Myriad Genetics, Inc. (MYGN) | | 07/20/2011 07:11:57 AM |
| Clovis Oncology plans $150 million IPO
By Beth Potter
6/23/2011 - 4:44:48 | Biotechnology Value Fund, L.P. | | 06/24/2011 06:00:44 AM |
| Mystery Ingredient in Coffee Boosts Protection Against Alzheimer's Disease, Stud | Nutrition | | 06/22/2011 02:43:57 PM |
| European Commission Approves Inclusion of Anti-JC Virus Antibody Status as a PM | Biogen - transition to operating company | | 06/22/2011 06:04:09 AM |
| European Commission Approves Inclusion of Anti-JC Virus Antibody Status as a PML | Elan Corporation, plc (ELN) | 1 | 06/22/2011 05:34:31 AM |
| Smith & Nephew, HTC, Hurtigruten, Google, Denison: Intellectual Property [Myriad | Myriad Genetics, Inc. (MYGN) | | 06/21/2011 08:53:16 AM |
| Supreme Court to Consider Patents on Medical Tests
JUNE 20, 2011, 4:34 P.M. | Myriad Genetics, Inc. (MYGN) | | 06/20/2011 05:31:30 PM |
| Array BioPharma Announces Restructuring
Aligning Resources with Clinical Prog | Biotech Restructurings | | 06/13/2011 07:45:52 PM |
| Array BioPharma Announces Restructuring
Aligning Resources with Clinical Prog | Array Pharmaceuticals ARRY | | 06/13/2011 07:42:06 PM |
| Cortex Enters into New Agreement with Servier
— CORTEX TO RECEIVE UP TO $3 | Cortex (Cor) [formerly CORX] | | 06/13/2011 07:48:06 AM |
| Some biotech start-ups can still make it on their own
Xconomy.Com [Boston Glo | Biotechnology Value Fund, L.P. | | 06/13/2011 07:16:56 AM |
| Biogen Seeking Deals to Expand Pipeline of MS Treatments
By Sasha Damouni - [ | Munch-a-Biotech Today | | 06/08/2011 10:20:57 AM |
| Rules-Based Medicine Reaches a Significant Milestone in Companion Diagnostic Pro | Myriad Genetics, Inc. (MYGN) | | 05/26/2011 09:57:12 AM |
| ASCO Abstract
Saturday June 4, 2:00 PM to 6:00 PM
| Myriad Genetics, Inc. (MYGN) | | 05/26/2011 09:04:12 AM |
| Alkermes to Merge with Elan Drug Technologies to C | Munch-a-Biotech Today | | 05/09/2011 08:25:13 AM |
| Alkermes to Merge with Elan Drug Technologies to Create Alkermes plc
— Creat | Elan Corporation, plc (ELN) | | 05/09/2011 08:21:28 AM |
| Alkermes to Merge With Irish Drug Business
By C | Elan Corporation, plc (ELN) | | 05/09/2011 07:53:10 AM |
| Myriad Genetics has entered into a definitive merger agreement to acquire privat | Munch-a-Biotech Today | | 04/28/2011 07:21:41 AM |
| Myriad Genetics Announces Agreement to Acquire Rules-Based Medicine
Acquisiti | Myriad Genetics, Inc. (MYGN) | | 04/28/2011 07:16:14 AM |
| Myriad Genetics Patent Appeal Case Arguments Begin April 4
By IB Times Staff | Myriad Genetics, Inc. (MYGN) | | 03/25/2011 07:16:45 AM |
| MYGN May Shift From Patents To Proprietary Data
(thanks to "Disambiguate" on Y | Myriad Genetics, Inc. (MYGN) | | 03/05/2011 03:59:23 PM |
| Sangamo Gene Therapy Shown to Be Safe in First Study in HIV
By Rob Waters and | Sangamo BioSciences, Inc. SGMO | | 02/28/2011 10:22:09 AM |
| Sangamo BioSciences Announces Presentation of Positive Clinical Data From Novel | Sangamo BioSciences, Inc. SGMO | | 02/28/2011 09:00:22 AM |
| Sangamo shares in biotech spotlight | Sangamo BioSciences, Inc. SGMO | | 02/26/2011 03:56:32 AM |
| Pharmaceuticals February 10, 2011, 5:00PM EST
Sangamo's Bet Against AIDS: Ge | Sangamo BioSciences, Inc. SGMO | | 02/11/2011 06:23:20 AM |
| Rejuvenation Research
Therapeutic Efficacy of Intranasally Delivered Mesenchy | Indications - Neurodegenerative | | 02/09/2011 11:34:10 PM |
| Myriad's PROLARIS(TM) Test Shown to Significantly Predict Prostate Cancer Outcom | Myriad Genetics, Inc. (MYGN) | | 02/09/2011 07:22:31 PM |
| Gene test may cut need for prostate cancer surgery | Myriad Genetics, Inc. (MYGN) | | 02/09/2011 07:49:00 AM |
| Myriad Test May Pinpoint Tumor Drug Success After | Myriad Genetics, Inc. (MYGN) | 1 | 01/28/2011 07:53:25 PM |
| Mizuho Initiates Coverage of Myriad Genetics
January 21, 2011
By a Genom | Myriad Genetics, Inc. (MYGN) | | 01/23/2011 02:44:19 AM |
| Link between Down syndrome, Alzheimer's disease di | Indications - Neurodegenerative | | 01/13/2011 08:13:30 AM |
| Researchers find new source of immune cells during pregnancy
December 16, 201 | Indications -- Autoimmunity/Immune-syste | | 12/17/2010 03:03:35 AM |
| UCSF - "fountain of youth" pill could restore aging immune system
Source:
K | Indications -- Autoimmunity/Immune-syste | 1 | 12/14/2010 06:55:15 PM |
| Myriad Acquires Novel Technology From Melanoma Diagnostics
Proprietary Techno | Myriad Genetics, Inc. (MYGN) | | 12/08/2010 07:44:11 PM |
| Array BioPharma Achieves Clinical Milestone in Celgene Collaboration
Press Re | Array Pharmaceuticals ARRY | | 11/30/2010 11:12:44 AM |
Copyright © 1995-2013 Knight Sac Media. All rights reserved.
